Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000781909 | SCV000920310 | likely benign | not specified | 2019-08-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002332572 | SCV002629444 | likely benign | Cardiovascular phenotype | 2021-05-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV002535703 | SCV003513824 | likely benign | Hypertrophic cardiomyopathy | 2024-01-30 | criteria provided, single submitter | clinical testing |